Trachoma vaccine trials are being conducted by several laboratories throughout the world. The degree of antigenic variation within the causative agent(s) of tra~zhoma is crucial to the success of these vaccines.
2. It is suggested that the term specific be subdivided to express the authors' exact meaning as follows: (a) disease-specific antigen to imply feline pneumonitis-specific, trachoma-specific, etc. (b) type-specific antigen to indicate strains of organisms within a disease entity which exhibit similar antigenic patterns to a given test, such as the mouse toxin test in trachoma. These may be categorized as types 1, 2, etc. The antigens in question are type-specific. (c) strain-specific antigen to indicate an individual strain within a given disease showing considerable individuality, temporarily or permanently resisting classification by type. Such waywardness may properly be termed strain specificity.
Materials and Methods Virus Strain Deslgnation.l--A description of the strains of trachoma virus employed in
these studies has been published (2) . The lymphogranuloma venereum (LGV) strain was LG-7, American Type Culture. Normal (non-infected) yolk sac is abbreviated NYS.
Antigens.--Antigens were prepared from infected crude yolk sacs as previously described (9, 10) . Absorbing and slide antigens were standardized by fourfold serial dilutions in M/15 phosphate-buffered saline (PBS), pH 7.2-7.4, to extinction of specific immunofluorescence. The final dilution showing definite fluorescence was designated 1 unit of antigen. Repetition of the test under these conditions yielded standardizations which rarely varied more than one tube either way.
Slide antigens were used at 160 or 320 units. Absorbing antigens were used at concentrations of 25 to 50 per cent yolk sac (64 to 4096 units as indicated in the tables). Four-hundred per cent concentrated and partially purified trachoma-absorbing antigens were occasionally used diluted in serum to a final concentration of 200 per cent.
At times, to achieve the proper units for slide antigens or to standardize antigens, it was TRIC/ /WAG/MRC-1/OT TANG TE-55 Gear, J. I-I. S., Gordon, F. B., Jones, B. R., and Bell, S. D., Jr., Nomenclature of isolates of viruses from trachoma and inclusion blennorrhea, Nature, 1963, 197, 26. necessary to dilute infected crude yolk sac beyond a 5 per cent suspension. To perceive minimal amounts of fluorescing antigen, these dilutions were carried out in S per cent normal yolk sac, thus assuring a uniform background stain with Evans blue ~ (9) against which the fluorescence could be observed.
Antigens have been divided into types i and 2, derived from the group I and II classification of Bell and Theobald (2) . Based on the results of the present paper Tang and G-I strains have been placed in a non-classified category.
An~isera.--Blood from a human volunteer (A. W.) vaccinated and infected (II) with SA-2 strain trachoma was utilized for the major portion of this study. Prior to vaccination the complement fixation (CF) titer against group antigen was less than 1:5. At a 1:2 dilution but not at 1:8 this prevaccination serum produced specific immunofluorescence of LGV and Tang yolk sac antigens. No fluorescent staining of SA-2 or G-I trachoma strains was obtained from this prebleeding at a 1:2 dilution. After 3 injections of formalin-killed trachoma strain SA-2 vaccine on days 0, 17, and 168, these titers remained unchanged. Serum taken at the time of infectious challenge failed to stain any of the tested slide antigens after absorption. Fourteen days after infection with trachoma strain SA-2 both the CF and |mmunofuorescent antibody titers began to rise. Serum (termed hereafter serum i) obtained on the 39th postinfection day~ titered at 1:16 by immunofuorescence, proved useful in absorption. Approximately 1 year later the titer had fallen to less than 1:2. The volunteer was revaccinated with strain SA-2 trachoma vaccine. Nine days after vaccination serum (designated serum 2) was obtained with immunofuorescent titers varying between 1:4 and 1:8 for type 1 slide antigens, and 1:8 to 1: 32 for both type 2 and the non-classified antigens. This serum was utilized successfully for these absorption studies.
Rabbit trachoma antiserum (12) , prepared by repeated intravenous inoculation of strain SA-2, was kindly supplied by Mr. Peter Reeve of the Lister Institute of Preventive Medicine, London.
Method of Absorption and
Staining.--Suspensionsof infected Crude yolk sac, diluted as described above, were placed on glass slides with a bacteriological loop. The plaques were approximately 5 mm in diameter; up to 10 could be placed on an ordinary glass slide. Thin smears were prepared for ease of reading. After drying on the bench, slide antigens were fixed in acetone at 20-25°C for 10 minutes. At -20°C these slides could be stored for months, before or after acetone fixation, without materially affecting the staining properties.
The serum to be absorbed was delivered by pipet into the bottom of a Kahn tube to avoid loss on the wall of the tube. Small amounts of serum were used but never less than 0.1 ml. An equal volume of absorbing antigen, suitably diluted, was added at a point just above the serum level. Mixture was by manual shaking. The serum-antigen mixture was incubated in a 37°C water bath for 60 minutes and left overnight at 4°C. During transfer from water bath to refrigerator the mixture was shaken vigorously.
Additional mixing was done by pipet immediately before the serum-antigen mixture was placed on the slide antigen plaque. As little as 0.003 ml of material was necessary for adequate coverage of the antigen plaque. Following incubation at 37°C for 30 minutes, the slides were washed vigorously for 10 minutes in two changes of PBS. Five to six drops of Evans blue, 1 per cent aqueous solution, were placed in this wash as a cotmterstain (9) . The plaques were covered with fluorescein-conjugated anti-human globulin obtained from several commercial sources, incubated and washed as before. The slides were rinsed in distilled water, dried, and mounted with buffered glycerine, pH 7.2, under a coverslip.
The optical system for immunofluorescence in use in our laboratory has been described (9) 2Nationai Aniline Division, Allied Chemical Corp., New York.
SEROLOGIC STRAIN DI~FEI~ENTIATION IN TRACHOMA

RESULTS
Absorption of Human Trachoma Antiserum.--Human trachoma antiserum was absorbed with 16 trachoma strains isolated from widely varying geographic areas. An LGV strain was also used as absorbing antigen. The absorption patterns (Table I) produced with serum 2 proved to be quite reproducible in repeated tests. It was observed that: +, fluorescent staining of slide antigen after exposure to absorbed serum. -, no fluorescent staining of slide antigen after exposure to absorbed serum.
§ In successive tests this absorbed serum yielded + and --results when tested against ASGH, SA-2, Hour.
H In successive tests this absorbed serum yielded + and --results when tested against SA-3, SA-6, ASGH, P-2, H-K, LT-1.
¶ In successive tests this absorbed serum yielded + and --results when tested against LT-1 and Tang slide antigens.
I. Homologous absorption was complete in every instance as evidenced by failure of slide antigens to stain when exposed to serum absorbed with the same strain.
2. Absorption of this antiserum with 8 trachoma strains from type I yielded serum which failed to react with type 1 slide antigens. Repeated absorptions with these absorbing antigens produced 132 separate tests; in no instance was staining of type I antigen observed. The same absorbed serum stained type 2 slide antigens regularly; repetitive tests yielded 68 positive stains in 84 tests of type 2 strains. Tang and LGV slide antigens were stained by this antiserum absorbed with type I strains.
3. Absorption with type 2 antigens yielded antiserum which failed to react with type I and type 2 slide antigens. In a total of 216 tests type 2-absorbed serum produced staining only 6 times, in each instance of type 2 slide antigens. Subsequent tests failed to confirm these 6 positive stains and they were judged aberrant. Serum absorbed with type 2 antigens reacted with Tang and LGV strains but failed to stain G-I.
4. G-I slide antigen reacted to serum 2, absorbed with various antigens, in a manner slmilar to the type 2 strains. However, SA-I absorbed antiserum did not stain G-I, and G-I absorbed serum reacted irregularly with Tang slide antigen. These two discrepancies made it advisable to place G-I in an unclassified category.
5. Absorption of this human trachoma antiserum with Tang and LGV antigens produced rather irregular staining in both types I and 2 slide antigens. The interlocking relationships of these isolates,--Tang and LGV,--were striking. No absorbing antigen removed antibody to the Tang strain except Tang itself.
LGV, and G-I (the latter irregularly). No absorbing antigen removed antibody to the LGV strain except LGV itself and Tang. It was concluded that Tang (TE-5S) and this strain of LGV were quite s{mHar antigenically.
Absorption of rabbit trachoma (SA-2) antiserum with these same antigens gave preliminary results which appeared to substantiate the difference between types I and 2 slide antigens demonstrated with human trachoma antiserum. Additional trials with animal antiserum will be undertaken when adequate amounts of serum can be obtained.
Controls and E~ence for Specificity.--Controls and evidence for specificity
which are applicable to all data recorded in this paper are summarized:
1. All tests were read and recorded while the microscopist was unaware of the strain of antigen present on the slide and/or the antigen used for absorbing the antiserum.
2. Normal yolk sac controls were always included; i.e., the serum under test was always absorbed with normal yolk sac and normal yolk sac was always present as a slide "antigen."
3. The anti-human globlllln conjugate failed to stain any of the slide antigens in the absence of trachoma antiserum.
4. Slide antigens were diluted to find the optimum concentration of virus permitting maximum intensity of stain with a weak antiserum. Dilutions tested ranged from 10 per cent in twofold dilutions down to 0.08 per cent. Slide antigens were easily visible at all concentrations. In consequence, slide antigens were standardized at 160 or 320 units in suspensions varying from 0.3 to 10 per cent crude infected yolk sac.
5. Absorbing antigens were not "standardized" in the sense that equal con ,-centrations of virus were used with each strain for absorption. The variation in the amount of virus in available yolk sac pools precluded such standardization. However, the concentration of virus per unit volume in the individual strains of absorbing antigens could be ascertained and is expressed in units in Table I . These unitages vary from 64 to 4096. Complete homologous absorption was obtained at both extremes of unitage and at each unit level between these two extremes. It was assumed, therefore, that absorbing antigen was present in considerable excess and that the variation in concentration of absorbing antigens would withstand scrutiny.
6. Absorption with crude yolk sac antigens was compared with parallel absorptions of 400 per cent concentrated and partially purified antigens (2) from the same strain. Using 6 strains of absorbing antigens and 20 strains of slide antigens, results of the crude and purified absorbing antigens were identical in 74 of 85 instances. It was concluded that the purification and concentration procedure did not alter this test.
7. In the technique described in this paper, the products of the absorption reaction were not removed prior to overlaying the slide antigen with the serumantigen mixture. To test the thesis that these products might in some way influence the results, they were removed. Two methods to effect removal were employed. The first involved a slow-speed centrifugation (1500 m,x¢, 10 minutes, 0-4°C) after which the supernatant was spun in a model L Spinco at high-speed (rotor No. 21, 20,000 RPM, 30 minutes, 0-4°C). The middle layer from this high-speed centrifugation was carefully removed with a fine pipet and tested as an absorbed antiserum or exposed a second time to absorbing antigen and centrifuged as before.
The second method for removing the products of the absorption reaction was to filter the antigen-antiserum mixture through a 5.0/~ Millipore filter followed by high-speed centrifugation as above. Whether absorbed once or twice, with products of the absorption reaction removed or not, the staining of the slide antigens was not materially affected. After removal of the absorption products only 16 of 218 readings were changed, in each case from positive to negative.
It was concluded that products of the antigen-antibody reaction present in the mixture overlying the slide antigen did not affect the outcome of the test.
8. Dissociation of the antigen-antibody complex under conditions of the test was investigated. Absorbed antiserum was used to stain slide antigens. This antigen-antiserum mixture was then placed at 4°C for 6 days and the slide antigens again stained. At the end of this period no difference in staining of slide antigens was observed. Antigen-antibody dissociation was not a significant factor in this technique.
9. Dilution of the absorbing antigen in 100 per cent normal yolk sac, instead of PBS, followed by centrifugation as before, changed only 3 of 21 readings from positive to negative.
10. Absorbing and slide antigen controls composed of normal yolk sac were included in each test. In addition normal yolk sac, used for absorption, was removed by centrifugation as described above, prior to application to the slide antigen. No change in the pattern of staining was observed after these procedures, 11. No immunofluorescence ( Fig. 1 ) of SA-2 slide antigen was visible after homologous absorption of human trachoma antiserum 2. A bright fluorescent stain (Fig. 2 ) of SA-2 slide antigen was seen after heterologous absorption of the same serum with SA-1 trachoma strain.
Quantitative Absorption Studies.--The type specificity noted in Table I may have been due to qualitative or quantitative variation of antigenic pattern in the trachoma virus strains. To investigate this, antigens were used in serial dilutions for absorption of the same serum. Text- fig. 1 graphically illustrates the immunofluorescent pattern derived from absorption of human trachoma antiserum 2 with progressively diminishing amounts of SA-1 antigen. The black areas indicate positive fluorescent stain and hence incomplete absorption. All type 1 slide antigens showed immunofluorescence when exposed to antiserum absorbed with 64 units of SA-1 antigen. The majority of these antigens failed to stain with antiserum absorbed with 128 units of antigen. In contrast, type 2 slide antigens continued to fluoresce after exposure to antiserum absorbed with 1024 units of SA-1 antigen.
This technique permitted an assessment of the variation in antigenic composition found in types 1 and 2 slide antigens. Approximately a tenfold increase in absorbing antigen was required to remove antibody reactive with type 2 as compared with type 1 slide antigens.
Text- fig. 2 depicts the same antiserum absorbed with diminishing amounts of SA-2 antigen. As in Table I , type 2-absorbing antigen removed antibody reactive both to types 1 and 2 with the exception of strain Bout. The failure of Egypt II slide antigen to stain is striking; no immunofluorescence was seen until only 4 units of absorbing antigen were used. Tang, G-l, and LGV continued to react with antiserum absorbed with the maximum unitage of antigen.
Text-figs. 1 and 2 were derived from the same antiserum used in Table I and may be compared with that table at the appropriate unitage of absorbing antigen.
Text- fig. 3 is a similar study using SA-2 absorbing antigen and human LGV strains first remarked in Table I above. Egypt II slide antigen failed to stain when exposed to antiserum absorbed with the least amount of antigen used; i.e., 0.1 per cent suspension (6.25 units). This individuality of Egypt II served to confirm the antigenic irregularity of this strain noted in Text- fig. 2 . The failure of Egypt I to stain was unexpected. Effect of Heat.--Slide antigens, absorbing antigens, or both were heated to 60°C for 60 minutes in a water bath prior to use. Antigens and antiserum were identical with those used in Table I . The results are shown in Table II .
Unheated controls yielded an absorption pattern entirely analogous to that of Table I . Heating the slide antigens led to an abrupt change. When heated, all slide antigens stained regardless of the absorbing antigen. Moreover, the brilliance of the stain was enhanced markedly.
Heating the absorbing antigens produced irregular staining in type 2 slide antigens. When both slide and absorbing antigens were heated, irregular stain was created in 3 of the 4 categories.
Because the slide and absorbing antigens were crude yolk sac, boiling temperatures coagulated the yolk sac and prevented accurate dilutions. Such attempts were abandoned.
These experiments appear to permit serologic strain differentiation of tra~choma isolates. However, the limitations of the method must be emphasized. The technique is restricted in practice by the scarcity of antisera of suitable titer and homogeneity. And a limitation in theory is imposed by lack of criteria to assess the relevancy of perceived antigenic differences to the problems of vaccine eflficacy in field trials.
The practical limitations are several in number. Early in the development ,of this work it was apparent that many of the anfisera available for testing could not be absorbed successfully. Sera with titers of 1: 8 or less usually failed to stain after absorption. Human antisera from vaccinated patients, though titered 1:32 or more by CF and fluorescent antibody, yielded inconsistent results. Mter absorption these postvaccination sera frequently failed to stain any of the trachoma slide antigens. Following challenge and infection with Srachoma, antiserum which could be utilized was obtained from a vaccinated volunteer. The antibody titer of this convalescent serum was not higher than titers found in postvaccination sera discussed above.
Attempts to produce suitable antisera in animals have not been successful in our laboratory. These studies have been handicapped by lack of antiserum to type 1 strains of trachoma virus.
Before vaccination or infection with a trachoma agent, screening of sera from animals or humans used in these studies frequently revealed the presence of PLT group antibody in low titer to one or more of the antigens under test. Failure to find antibodies was not considered sufficient evidence to warrant the assumption that a monovalent antibody response in humans or in animals would be evoked by vaccination or infection with a trachoma agent. The PLT agents, notoriously poor antibody producers (13), may elicit a temporary antibody response; subsequent stimulation with trachoma antigen of a subject in which no PLT antibodies are detectable may then produce an anamnestic response which yields an antibody population of moderate to gross heterogeneity.
In these series of experiments it is doubtful if any of the sera studied conrained only a single species of antibody to a given strain of trachoma. Some variability of the results of absorptions in sera from varying sources was expected and found. With a given antiserum the results were consistent and reproducible.
Heterogeneity of the antigens, as well as of the antibody population, could be expected to affect the reproducibility of the results. There is little assurance that a designated trachoma strain contains, in fact, only one serologically distinct population of virus. Mixed infections may exist in the eye and be represented in the original isolates. Laboratory contamination may intrude to destroy the homogeneity of a given strain. Mutation or selective passage in eggs may alter the growth and virulence characteristics of the virus (12) with unknown effects on serologic strain specificity.
The fluorescent antibody test, as described in this paper, necessitates a subjective evaluation. Experience is required to recognize minimal degrees of immtmofluorescence of various PLT strains. Each strain stains somewhat differently. Nevertheless, with experience nearly identical readings can be obtained by microscopists working independently. Correlation of repetitive tests in the opinion of the authors is excellent for a serologic technique.
The limitations in theory are more formidable. When attempting to approach immunologic specificity, the heterogeneity of the antibody population constitutes the most important obstacle. Burnet has stated (14) and reaffirmed (15) that, with bacteria at least, there is no evidence for the presence of a mosaic of antigens on the bacterial surface; the evidence is for diversity in the antibody population, not in the antigen population. The assumption is that any antigenic molecule carries a variety of potential antigenic determinants, but that any antiserum will contain antibody molecules carrying complementary groupings not representative of the whole antigen.
Burnet points out that the system concerned with antibody production, i.e. the virus particle presumably in the process of disintegration in the antibody-producing cells of the host, is different from the virus particle with which the antiserum reacts in an experimental test (15). Thus it was reasonable that Hirst (16), using influenza A virus to absorb immune sera, should find both large and small antigenic differences even with strains isolated in the same epidemic. He postulated an infinite variety of antigenic patterns with exceedingly complex interrelationships, a view fortified by the somewhat conflicting attempts at compression of influenza A strains into broad groups.
A similar situation may pertain to the trachoma strains under study. Bedson, in his classic monograph on the antigenic composition of psittacosis virus, first reported enhancement of antigenic activity by heating and still further improvement by boiling of psittacosis elementary body suspensions. Bedson concluded that heating probably destroyed something on the surface of the virus bodies and so unmasked the PLT group antigen which was heat-stable (5).
After 27 years, this observation by Bedson on the role of heat in altering the antigenicity of PLT viruses remains empiric. No rational explanation has supervened to open new insights into the phenomenon of antigenic enhancement in the PLT group by boiling. In the present example temperatures were limited to 60°C. Yet the results were clear-cut. Before heating, in 3 of the 4 categories no antigen-antibody reaction took place in sufficient degree to permit an observable stain. After the slide antigens were heated, a brilliant stain in all 4 categories was apparent. The antigen-antiserum mixture was unchanged; 60°C heat had effected a marked change in the slide antigen, altering or uncovering the antigens in some unknown way to permit a reaction to Occur.
Burnet's postulate of antibody heterogeneity seems applicable to this experiment. Antibody incapable of reacting with unheated slide antigens was present in this antiserum after absorption with various antigens; heat-altered antigen reacted with this antibody producing a brilliant stain.
Setting aside the practical and theoretical limitations, several advantages of this method are obvious. In other types of serologic tests to increase the specificity of sera, absorption of a cross-reacting antibody is laborious because the products of the reaction must be removed, usually by centrifugation or filtration. It is an advantage of the immunofluorescent technique that this step is obviated, for the antigen of the indicating reaction is fixed to the slide. The products of the absorbing reaction are removed by the usual washing procedures and do not interfere with the reading of the experimental results. Furthermore, the volume of reagents needed is small so that little absorbing antigen is required.
The degree of antigenic variation, noted to be greater with the first of the two antisera obtained from the human volunteer, may be significant. It appears that the first serum (Text- fig. 3 ) is more sensitive to antigenic differences in the slide antigens than is the second serum (Text-fig. 2 ). This may be due to a gradual broadening in the specificity of the antibody response with time, or to a decrease in specificity induced by the vaccine booster, or both.
Whether the type-specific antigenic variation described in this paper represents a qualitative or a quantitative difference between strains merits serious consideration. A significant quantitative variation in the antigens of trachoma strains types 1 and 2 is apparent in the results presented. The antiserum used was of low titer, 1:4 to 1:32 depending upon the trachoma strains tested. A tenfold increase in absorbing antigen, applied to this low titered antiserum, was insufficient to eliminate the antigenic disparity. Repeated absorptions, up to the point of exhaustion of the antiserum, also failed to delete the antigenic variation between trachoma slide antigens of type 1 versus type 2. In the opinion of the authors a divergence of this magnitude is compatible with, but does not prove, a qualitative difference in the antigenic structure of the two types of trachoma strain isolates. A more critical analysis must await the availability of trachoma antiserum of relative homogeneity and high titer.
From this study of 19 trachoma virus strains one gains the impression of antigenic patterns with complex interrelationships. However, for purposes of vaccination of patients the antigenic variation per se is unimportant; rather, the immunologic heterogeneity as it pertains to an antitoxic or an antiinfective vaccine should concern us. Minor or major disparities in antigen structure, as revealed by a given CF, agglutination, or serum absorption test such as described in this paper, may have no bearing on the immunological protection afforded a patient by a vaccine. At this juncture, a relation between serologic test and vaccine efficacy can be verified only in a field vaccine trial.
Type-and strain-specific relationships in the trachoma isolates studied have been demonstrated by the in vitro technique described in this paper. The practical significance of these findings remains to be explored.
S~ARY
An in vitro test for the differentiation of trachoma strain isolates was described. The method was based on absorption of trachoma antiserum followed by immunofluorescent stainlug of individual trachoma strains.
Nineteen trachoma strains were studied; two main types were identified. Evidence for quantitative and qualitative antigenic variation between the two types was presented. The limitations in practice and in theory of the test were emphasized.
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